Granules India Gets ANDA Nod for Methocarbamol Tablet | CORPORATE ETHOS

Granules India Gets ANDA Nod for Methocarbamol Tablet

By: | May 8, 2018
granules

May 7: Hyderabad-based drug maker Granules India Ltd on Tuesday said that the US Food and Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by the company for its Methocarbamol Tablet 500 mg and 750 mg.

According to the company, the approved ANDA is the bioequivalent to Reference Listed Drug (RLD) of Robaxin 500 mg and 750 mg of Auxilium Pharmaceuticals LLC.

“Granules India Ltd intends to commercialise this product shortly,” it said.

Shares of the company were trading at Rs 101.25, up 0.90% from the previous closing of Rs 100.35, on BSE at 10.25 am today.